PURA Short Squeeze Potential Can Catapult PPS Even Higher Than $0.25 52-Week High
- Short Selling Hit PURA Today In The Middle Of Week Long PR Campaign
- But Short Sales Struck Too Early In The Week With More PURA News On The Way
- Short Squeeze Could Now Send PURA PPS Higher Than $0.25 52-WK High
- New Sales And Products Still To Be Reported This Week
- New Analyst Research Report Coming This Week
September 24, 2019 -- InvestorsHub NewsWire -- via www.nextbigticker.com -- Puration, Inc. (USOTC: PURA) has been experiencing a MAJOR BULL RUN starting last week under $0.05 and reaching a high over $0.09 today. Then lunchtime brought on a short attack driving the PPS back down to the $0.07 range and doubling the trading volume. However, the short sellers may have miscalculated the timing of their attack. It’s only Tuesday, and PURA has announces a week-long series of corporate announcements coming this week. It’s unlikely the company started the week with its strongest news. The fastest runner always runs anchor on the relay. The short sellers may end up helping to drive the PURA PPS even higher than what might have been reached without their untimely short attack.
The PURA Bull Run started last week when Goldman Small Cap Research last Wednesday published CBD Beverage Industry Survey results in conjunction with PURA’s latest CBD Beverage marketing initiative. Goldman’s results were accompanied by a confirmation of an earlier Analyst Research Speculative BUY Recommendation and $0.25 PPS Target Price. The company has a 52-week high of $0.25 supporting the recent analyst update. The company has indicated a more detailed Goldman update is coming this week. A further confirmation of the $0.25 recommendation would be a strong indicator of the PURA PPS potential. Given the 52-week high of $0.25, a recommendation of an even higher PPS target would is not out of the question.
PURA has reported over $1 million in sales for the first six months of 2019 after reporting $1 million in sales for all of 2018. The company has target selling $4 million in CBD infused beverages this year.
PURA’s EVERx CBD Sports Water utilizes Kali-Extracts’ (USOTC: KALY) U.S. Patented Cannabis Extraction Process. PURA holds the only license of the Patent for use in a beverage. KALY has recently made news with the filing of a new Patent for a cannabis extract to treat COPD. PURA may have benefited from recent KALY news.
PURA’s EVERx CBD Sports Water is available for sale online through the website www.USMJ.com from North American Cannabis Holdings, Inc. (USOTC: USMJ).
PURA news from the Arnold Sports Festival in Europe is hitting wires now. The company has announced the rollout of its European marketing program launching at the Arnold in Barcelona which started today.
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.